(Q48022836)

7 February 2018

title

Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study (English)

1 reference

7 February 2018

1 reference

Naji Salem

1

1 reference

7 February 2018

Michelle Simonian-Sauve

2

1 reference

7 February 2018

Roland Rosello

3

1 reference

7 February 2018

Claude Alzieu

4

1 reference

7 February 2018

Gwenaelle Gravis

5

1 reference

7 February 2018

Dominique Maraninchi

6

1 reference

7 February 2018

Franck Bladou

7

1 reference

7 February 2018

publication date

1 February 2003

1 reference

7 February 2018

Radiotherapy and Oncology

published in

1 reference

7 February 2018

volume

66

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

159-165

1 reference

7 February 2018

Complications after prostate brachytherapy in the Medicare population

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Prostate brachytherapy: importance of technique

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Palladium-103 brachytherapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Urinary morbidity with a modified peripheral loading technique of transperineal (125)i prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Acute urinary morbidity following I-125 interstitial implantation of the prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Complications of treatment for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Late GI and GU complications in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900004-5

7 January 2021

10.1016/S0167-8140(03)00004-5

Identifiers

DOI

1 reference

7 February 2018

release_ybym4r5cnvepjag7jbl2yzwnbq

Fatcat ID

0 references

1 reference

7 February 2018